Belpointe Asset Management LLC Sorrento Therapeutics, Inc. Transaction History

Belpointe Asset Management LLC

  • $1.49 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$0.74 - $1.83 $13,226 - $32,707
17,873 New
17,873 $15,000
Q4 2021

Feb 15, 2022
SELL
$4.65 - $7.23 $74,041 - $115,123
-15,923 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$7.41 - $10.99 $2,964 - $4,396
-400 Reduced 2.45%
15,923 $121,000
Q2 2021

Aug 09, 2021
BUY
$6.35 - $10.0 $14,605 - $23,000
2,300 Added 16.4%
16,323 $158,000
Q1 2021

May 14, 2021
BUY
$7.03 - $16.51 $98,581 - $231,519
14,023 New
14,023 $116,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email